352 related articles for article (PubMed ID: 29270777)
21. Association between polymorphisms in the promoter region of pri-miR-34b/c and risk of hepatocellular carcinoma.
Chen LL; Shen Y; Zhang JB; Wang S; Jiang T; Zheng MQ; Zheng ZJ; Chen CX
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808368
[TBL] [Abstract][Full Text] [Related]
22. Pri-miR-34b/c rs4938723 polymorphism is associated with a decreased risk of gastric cancer.
Pan XM; Sun RF; Li ZH; Guo XM; Qin HJ; Gao LB
Genet Test Mol Biomarkers; 2015 Apr; 19(4):198-202. PubMed ID: 25658980
[TBL] [Abstract][Full Text] [Related]
23. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
[TBL] [Abstract][Full Text] [Related]
24. MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population.
Wei J; Zheng L; Liu S; Yin J; Wang L; Wang X; Shi Y; Shao A; Tang W; Ding G; Liu C; Chen S; Gu H
Hum Immunol; 2013 Sep; 74(9):1199-205. PubMed ID: 23792053
[TBL] [Abstract][Full Text] [Related]
25. Circulating Interleukin-6 is Associated with Prognosis and Genetic Polymorphisms of MIR608 in Patients with Esophageal Squamous Cell Carcinoma.
Yang PW; Huang PM; Yong LS; Chang YH; Wu CW; Hua KT; Hsieh MS; Lee JM
Ann Surg Oncol; 2018 Aug; 25(8):2449-2456. PubMed ID: 29948421
[TBL] [Abstract][Full Text] [Related]
26. Pri-miR-34b/c rs4938723 Polymorphism is Associated with Decreased Risk and Better Prognosis for Colorectal Cancer Patients.
Kassim SA; Yang X; Abbas M; Wu S; Faran Ashraf Baig MM; Meng QT; Zhang C; Li X; Chen R
Arch Med Res; 2019 Feb; 50(2):55-62. PubMed ID: 31349954
[TBL] [Abstract][Full Text] [Related]
27. The Rs4938723 Polymorphism Reduces Expression of MicroRNA-34b and Increases the Risk of Recurrence after Endoscopic Dissection in Early Gastric Cancer.
Yu K
Cell Physiol Biochem; 2017; 43(3):1235-1246. PubMed ID: 28977792
[TBL] [Abstract][Full Text] [Related]
28. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
Sun N; Ye L; Chang T; Li X; Li X
Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
Lin X; Xu XY; Chen QS; Huang C
Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of miR-34b/c polymorphisms to the risk of ischemic stroke.
Wei G; Liao C; Jian C; Liang L; Liu J; Tang Y; Wei Y
J Hypertens; 2020 Aug; 38(8):1481-1487. PubMed ID: 32149930
[TBL] [Abstract][Full Text] [Related]
31. Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma.
Xue L; Nan J; Dong L; Zhang C; Li H; Na R; He H; Wang Y
Cancer Biomark; 2017; 19(2):193-197. PubMed ID: 28211800
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
[TBL] [Abstract][Full Text] [Related]
33. Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.
Wang C; Guan S; Liu F; Chen X; Han L; Wang D; Nesa EU; Wang X; Bao C; Wang N; Cheng Y
Br J Cancer; 2016 Feb; 114(3):290-7. PubMed ID: 26794279
[TBL] [Abstract][Full Text] [Related]
34. Homozygous GNAS 393C-allele carriers with locally advanced esophageal cancer fail to benefit from platinum-based preoperative chemoradiotherapy.
Alakus H; Bollschweiler E; Hölscher AH; Warnecke-Eberz U; Frazer KA; Harismendy O; Lowy AM; Mönig SP; Eberz PM; Maus M; Drebber U; Siffert W; Metzger R
Ann Surg Oncol; 2014 Dec; 21(13):4375-82. PubMed ID: 24986238
[TBL] [Abstract][Full Text] [Related]
35. High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Zhou XL; Wang WW; Zhu WG; Yu CH; Tao GZ; Wu QQ; Song YQ; Pan P; Tong YS
Mol Carcinog; 2016 Dec; 55(12):2095-2105. PubMed ID: 26756568
[TBL] [Abstract][Full Text] [Related]
36. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
[TBL] [Abstract][Full Text] [Related]
37. Genetic variants in miR-196a2 and miR-499 are associated with susceptibility to esophageal squamous cell carcinoma in Chinese Han population.
Shen F; Chen J; Guo S; Zhou Y; Zheng Y; Yang Y; Zhang J; Wang X; Wang C; Zhao D; Wang M; Zhu M; Fan L; Xiang J; Xia Y; Wei Q; Jin L; Wang J; Wang M
Tumour Biol; 2016 Apr; 37(4):4777-84. PubMed ID: 26518769
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness.
Chen YZ; Cui XB; Hu JM; Zhang WJ; Li SG; Yang L; Shen XH; Liu CX; Pan QF; Yu SY; Yuan XL; Yang L; Gu WY; Chen JZ; Wang LD; Li F
APMIS; 2013 Oct; 121(10):908-18. PubMed ID: 23659763
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of miR-34b/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas.
Supic G; Stefik D; Ivkovic N; Sami A; Zeljic K; Jovic S; Kozomara R; Vojvodic D; Stosic S
Sci Rep; 2022 Jan; 12(1):1296. PubMed ID: 35079080
[TBL] [Abstract][Full Text] [Related]
40. Prognostic role of microRNA polymorphisms in patients with advanced esophageal squamous cell carcinoma receiving platinum-based chemotherapy.
Wu C; Li M; Hu C; Duan H
Cancer Chemother Pharmacol; 2014 Feb; 73(2):335-41. PubMed ID: 24288122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
